ACRYSOF® Toric NATURAL T9 Intraocular Lens (IOL)

Exclusion Criteria

• •Irregular corneal astigmatism;
• •Keratopathy/Keratectasia - any corneal abnormality, other than regular corneal astigmatism, including but not limited to the following; keratoconus, keratoglobus, keratolysis, keratomalacia, keratomycosis, and corneal plana;
• •Any inflammation or edema (swelling) of the cornea, including but not limited to the following; keratitis, keratoconjunctivitis, and keratouveitis;
• •Previous corneal refractive surgery;
• •Subjects with diagnosed degenerative visual disorders (e.g., macular degeneration or other retinal disorders) that are predicted to cause future acuity losses to a level worse than 0.2 logMAR;
• •Amblyopia;
• •Clinically severe corneal dystrophy (e.g., epithelial, stromal, or endothelial dystrophy);
• •Diabetic retinopathy;
• •Extremely shallow anterior chamber, not due to swollen cataract;
• •Microphthalmos;
• •Previous retinal detachment;
• •Previous corneal transplant;
• •Recurrent severe anterior or posterior segment inflammation of unknown etiology;
• •Rubella or traumatic cataract;
• •Iris neovascularization;
• •Uncontrolled glaucoma;
• •Aniridia;
• •Optic nerve atrophy;
• •Pregnancy;
• •Any subject currently participating in another investigational drug or device study that may confound the results of this investigation.